| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/11/2009 | EP1603541B1 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| 11/11/2009 | EP1594868B1 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 11/11/2009 | EP1575964B1 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 11/11/2009 | EP1557407B1 Novel alpha-ketoamide derivatives and use thereof |
| 11/11/2009 | EP1537104B1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
| 11/11/2009 | EP1495762B1 Therapeutic lotion for dermatitis |
| 11/11/2009 | EP1492487B1 Mitotic kinesin inhibitors |
| 11/11/2009 | EP1490120B1 Embolization |
| 11/11/2009 | EP1482795B1 New immunoeffector compounds |
| 11/11/2009 | EP1477186B1 Antipruritics |
| 11/11/2009 | EP1451203B1 3-beta-d-ribofuranosylthiazolo(4,5-delta)pyridimine nucleosides and uses thereof |
| 11/11/2009 | EP1450856B1 Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use |
| 11/11/2009 | EP1430896B1 Nicotine-containing film preparation |
| 11/11/2009 | EP1427418B1 Piperazinone compounds as anti-tumor and anti-cancer agents |
| 11/11/2009 | EP1406870B1 Taxol enhancer compounds |
| 11/11/2009 | EP1401451B1 Quinazoline derivatives which promote the release of parathyroid hormone |
| 11/11/2009 | EP1397351B1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors |
| 11/11/2009 | EP1381587B1 Glycerol-peg-derivatives as inhibitors of cyclooxygenase-2 and phospholipase-a2 |
| 11/11/2009 | EP1372634B1 Use of fumaric acid amides |
| 11/11/2009 | EP1364659B1 Remedies for urinary diseases comprising lpa receptor controlling agents |
| 11/11/2009 | EP1339673B1 Malonamide and malonamic ester derivatives with antithrombotic activity, their preparation and their use |
| 11/11/2009 | EP1320369B1 A method of analgesia |
| 11/11/2009 | EP1317286B1 Administration form for hormonal contraception |
| 11/11/2009 | EP1317278B1 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 11/11/2009 | EP1315812B1 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 11/11/2009 | EP1313734B1 Aza heterocyclic derivatives and their therapeutic use |
| 11/11/2009 | EP1312369B1 Cardiac arrest fluid |
| 11/11/2009 | EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils |
| 11/11/2009 | EP1196163B1 Pharmaceutical compositions for the treatment of insulin resistance |
| 11/11/2009 | EP1181048B1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
| 11/11/2009 | EP1174140B1 Chromanol glycosides for use in the treatment of dermopathy caused by ultraviolet light |
| 11/11/2009 | EP1158976B1 VACUOLAR-TYPE (H+)-ATPase-INHIBITING COMPOUNDS, COMPOSITIONS, AND USES THEREOF |
| 11/11/2009 | CN201341508Y Physical therapy insole with the integrated heath-care efficiency |
| 11/11/2009 | CN101578287A Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| 11/11/2009 | CN101578285A Condensed pyridine compound |
| 11/11/2009 | CN101578284A Agent for improving insulin resistance |
| 11/11/2009 | CN101578283A Crystalline forms of thiazolidinedione derivative and its manufacturing method |
| 11/11/2009 | CN101578280A Benzoquinazole derivatives |
| 11/11/2009 | CN101578279A Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors |
| 11/11/2009 | CN101578277A 5-substituted isoindoline compounds |
| 11/11/2009 | CN101578276A Composition comprising (-)-delta-trans-tetrahydrocannabinol |
| 11/11/2009 | CN101578275A Anilinopiperazine derivatives and methods of use thereof |
| 11/11/2009 | CN101578273A Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 11/11/2009 | CN101578272A 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors |
| 11/11/2009 | CN101578271A 4-imidazolines as TAAR's ligands |
| 11/11/2009 | CN101578270A Process for the sulfinylation of a pyrazole derivative |
| 11/11/2009 | CN101578269A N- (methyl) -1h- pyrazol- 3 -amine, n- (methyl) -pyridin-2-amine and n- (methyl) -thiaz0l-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. |
| 11/11/2009 | CN101578268A Novel compounds and methods for their production |
| 11/11/2009 | CN101578266A Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives |
| 11/11/2009 | CN101578265A Sulfonamide derivatives as chymase inhibitors |
| 11/11/2009 | CN101578263A Sulfonamides and their use as a medicament |
| 11/11/2009 | CN101578259A 1,4 diamino bicyclic retigabine analogues as potassium channel modulators |
| 11/11/2009 | CN101578120A Compounds and compositions as channel activating protease inhibitors |
| 11/11/2009 | CN101578116A Processes to prepare antimicrobial contact lenses |
| 11/11/2009 | CN101578101A Sinomenine derivatives and preparation and uses thereof |
| 11/11/2009 | CN101578100A Use of neuroprotective compounds for obtaining drugs for treating neurodegenerative diseases |
| 11/11/2009 | CN101578099A Use of carboxyamidotriazole (CAI) orotate in macular degeneration |
| 11/11/2009 | CN101578098A Drug, drug induction device, magnetic detector and method of designing drug |
| 11/11/2009 | CN101578097A Anesthetic spray composition |
| 11/11/2009 | CN101578096A Robust sustained release formulations |
| 11/11/2009 | CN101578095A Robust sustained release formulations |
| 11/11/2009 | CN101578094A Robust sustained release formulations of oxymorphone and methods of use thereof |
| 11/11/2009 | CN101578091A Composition for external application to skin |
| 11/11/2009 | CN101578042A Prevention of nuclear, solar, and other radiation-induced tissue damage |
| 11/11/2009 | CN101575602A siRNA sequence for inhibiting human BFGF gene expression amplification and expression carrier and application thereof |
| 11/11/2009 | CN101575341A Amidocyanogen amido xanthone pyridine derivant, and preparation method and application thereof |
| 11/11/2009 | CN101575339A 8-hydroxypyrimido-[3,2-d]pyrimidine-7-carboxylic acid derivatives having anti-HIV activity, preparation method thereof and use thereof |
| 11/11/2009 | CN101575336A N-aryl piperazine derivative and preparation method thereof and drug composition adopting N-aryl piperazine derivative as active ingredient |
| 11/11/2009 | CN101575335A Dehydrogenated silibinin substituted by meta-chlorobenzene formoxyl, preparation method and pharmaceutical applications thereof |
| 11/11/2009 | CN101575333A Quinazoline derivatives and medical application thereof |
| 11/11/2009 | CN101575330A Novel voriconazole broad-spectrum antifungal medicine compound, broad-spectrum antifungal medicine composition and application thereof |
| 11/11/2009 | CN101575327A Antimalarial active isocumarans compound and composition, preparation method and application thereof |
| 11/11/2009 | CN101575320A Water-soluble triazole antifungal compound |
| 11/11/2009 | CN101575318A Novel dihydropyridine compound and application thereof on preparing drugs for curing and/or preventing virus diseases |
| 11/11/2009 | CN101575316A Method for separating and preparing 2-hydroxyl-1-methoxy aporphine from lotus leaves |
| 11/11/2009 | CN101575315A New naphthalimide derivative, preparation method and application thereof |
| 11/11/2009 | CN101575314A Dihydropyridine compounds and application thereof on preparing drugs for curing and/or preventing virus diseases |
| 11/11/2009 | CN101574552A Inhalation kit comprising inhalable powder of tiotropium |
| 11/11/2009 | CN101574527A Liver-targeting intelligent nano-micelle prodrug system and preparation thereof |
| 11/11/2009 | CN101574525A Hydroxypropyl-beta-cyclodextrin inclusion compound for lipophilic medicaments, and preparation method thereof |
| 11/11/2009 | CN101574524A Sulfoalkyl ether cyclodextrin inclusion compound for lipophilic medicaments, and preparation method thereof |
| 11/11/2009 | CN101574520A Methods of administering anti-TNF alpha antibodies |
| 11/11/2009 | CN101574519A Method for preventing or treating opiate resistance and dependency |
| 11/11/2009 | CN101574513A Stomachic hericium erinaceum polysaccharide health-care capsule |
| 11/11/2009 | CN101574505A Tibetan medicine aerosol for treating acute and chronic sprains and contusions, rheumatism and rheumatoid disease |
| 11/11/2009 | CN101574504A Medical composition for treating mammary gland diseases and preparation method thereof |
| 11/11/2009 | CN101574501A Sanchi and combined spicebush root paste used for preventing and treating cervical spondylosis |
| 11/11/2009 | CN101574496A Western and traditional Chinese medicine tincture for treating facial colour spot |
| 11/11/2009 | CN101574478A Western and traditional Chinese medicine tincture for treating acne mark |
| 11/11/2009 | CN101574462A Drug composition for reducing blood sugar and blood fat and curing diabetes |
| 11/11/2009 | CN101574461A Drug composition for reducing blood sugar and blood fat and curing diabetes |
| 11/11/2009 | CN101574444A Rehabilitation medication combination for curing addiction to morphine drugs and preparation method thereof |
| 11/11/2009 | CN101574443A Rehabilitation medication combination for curing addiction to morphine drugs and preparation method thereof |
| 11/11/2009 | CN101574438A Drug composition for reducing blood sugar |
| 11/11/2009 | CN101574437A Drug composition for reducing blood sugar |
| 11/11/2009 | CN101574436A Drug composition for reducing blood sugar |
| 11/11/2009 | CN101574435A Drug composition for reducing blood sugar |
| 11/11/2009 | CN101574434A Drug composition for reducing blood sugar |
| 11/11/2009 | CN101574433A Drug composition for reducing blood sugar |
| 11/11/2009 | CN101574428A Vagina repair gel and preparation method thereof |